Top 5 Trends in the Global COPD Market: Insights from Spherical Insights and Consulting
According to a research report by Spherical Insights & Consulting, the Global Chronic Obstructive Pulmonary Disease (COPD) Market is projected to expand from USD 18.20 billion in 2021 to USD 35.90 billion by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 8.2% over the forecast period.
Get a free sample PDF:https://www.sphericalinsights.com/request-sample/1575
Asthma is a chronic, inflammatory lung condition that affects the airways and is not contagious. It is characterized by recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, resulting from airway hyperresponsiveness. Compared to other obstructive lung diseases, asthma is relatively treatable, with allergies being the primary risk factor. Other triggers include irritants, physical exertion, cold air, pets, and dust.
Chronic Obstructive Pulmonary Disease (COPD), in contrast, involves irreversible airflow restriction and is not completely curable. COPD encompasses emphysema, which involves the destruction of the alveoli, and chronic bronchitis, marked by persistent inflammation of the lower respiratory tract. Tobacco use is the main cause of COPD. Diagnosis of both asthma and COPD can be made through physical exams and various tests, including X-rays, sputum eosinophil counts, and nitric oxide measurements.
Browse key industry insights spread across 210 pages with 122 market data tables and figures & charts from the report the “Global Chronic Obstructive Pulmonary Disease Market Size, Share, and COVID-19 Impact Analysis, By COPD Type (Chronic Bronchitis, Emphysema), By Treatment-Type (Drugs, Oxygen Therapy), By End-User (Hospitals, Clinics), by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030 "
Buy Now Full Report:https://www.sphericalinsights.com/checkout/1575
"The Chronic Bronchitis segment holds the largest market share and is expected to continue dominating throughout the forecast period."
The global Chronic Obstructive Pulmonary Disease (COPD) market is segmented by type into Chronic Bronchitis and Emphysema. Currently, the Chronic Bronchitis segment holds the largest market share and is expected to continue leading throughout the forecast period. This dominance is attributed to the rising incidence and prevalence of chronic bronchitis, driven by increased cigarette consumption, higher levels of industrialization, and the release of harmful chemicals into the environment. These factors contribute to the growing number of chronic bronchitis cases, thereby fueling the market's expansion.
The Drugs segment is projected to hold the largest market share throughout the forecast period.
The global chronic obstructive pulmonary disease (COPD) market is segmented by treatment type into Drugs, Oxygen Therapy, Surgery, and Others. Among these, the Drugs segment is expected to hold the largest market share throughout the forecast period. The primary reliance on medications to manage COPD by opening airways and easing breathing has significantly driven the growth of this segment.
Inquire Before Buying This Research Report:https://www.sphericalinsights.com/inquiry-before-buying/1575
North America is projected to lead the market, holding the largest market share throughout the forecast period.
In 2020, North America led the global chronic obstructive pulmonary disease (COPD) market in revenue and is expected to continue dominating throughout the forecast period. This leadership is primarily due to substantial investments in research and development for new treatments targeting chronic respiratory diseases and lifestyle-related conditions. Key factors contributing to the market growth in the region include the increasing prevalence of chronic respiratory issues, advancements in technology, an expanding healthcare sector, and the significant presence of major industry players.
The Hospitals segment is dominating the market with the largest market share over the forecast period.
On the basis of end user, the global Chronic Obstructive Pulmonary Disease Market is segmented into Hospitals, Clinics, Homecare Settings, and Others. Among these, the hospitals segment is dominating the market with the largest market share over the forecast period because the prevalence of many chronic respiratory diseases and lifestyle disorders is increasing, as is public awareness of these illnesses. Also, the availability of various diagnostic and treatment facilities, higher purchasing power, and the presence of highly skilled healthcare professionals are encouraging the growth of the hospital segment of the worldwide chronic obstructive pulmonary disease market.
Competitive Analysis:
Chronic Obstructive Pulmonary Disorder (COPD) is a chronic inflammatory lung condition characterized by obstructed airflow from the lungs. Symptoms of COPD include wheezing, coughing up phlegm, and difficulty breathing. The condition is often caused by prolonged exposure to irritant chemicals and particulates, most commonly from cigarette smoke. COPD can also lead to serious health issues such as heart disease, lung cancer, and other medical conditions. It commonly includes two main disorders: emphysema and chronic bronchitis. Chronic bronchitis involves inflammation of the lining of the bronchial tubes, which are responsible for carrying air to and from the lungs' alveoli.the major challenges in AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, CHIESI Farmaceutici SpA, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Orion Corporation, Merck & Co., Inc, Grifols, S.A., Abbott, F. Hoffmann-La Roche Ltd, Vectura Group plc, Pfizer Inc, Alkermes, Mylan N.V, Almirall, S.A, Genentech, Inc, Biogen, and Astellas Pharma Inc.
Get Discount At @https://www.sphericalinsights.com/request-discount/1575
Market Segment
This study forecasts revenue at global, regional, and country levels from 2021 to 2030. Spherical Insights has segmented the global Chronic Obstructive Pulmonary Disease market based on the below-mentioned segments:
?
Chronic Obstructive Pulmonary Disease Market, By COPD
?
Chronic Obstructive Pulmonary Disease Market, By Treatment Type
?
领英推荐
Chronic Obstructive Pulmonary Disease Market, By End User
?
Chronic Obstructive Pulmonary Disease Market, Regional Analysis
Browse Related Reports:
Global Burn Care Market - Industry Trends and Forecast to 2033
Diabetes Associated Ophthalmic Treatment Market Size, Share, Trend - 2033
Dentures Market Size, Growth, Trend, Industry Report, Forecast - 2033
Global Biohacking Market Share, Trend, Forecasts to 2033
About the Spherical Insights?& Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone:?+91 90289 24100 (APAC)
Email: [email protected], [email protected]
Contact Us: https://www.sphericalinsights.com/contact-us